Efficacy of adefovir dipivoxil in treatment of chronic hepatitis B patients with non-alcoholic fatty liver disease
-
摘要:
<正>近年来,慢性乙型肝炎(CHB)合并非酒精性脂肪性肝病(NAFLD)的患者在临床上越来越常见。有报道显示27%~76%的CHB患者合并NAFLD[1]。NAFLD常促进原有基础肝病的进展,影响原有肝病治疗的疗效,如HBV感染者合并NAFLD,NAFLD可促进其肝硬化和肝细胞癌的发生[2];慢性丙型肝炎(CHC)患者合并NAFLD,NAFLD可降低非基因3型
-
Key words:
- hepatitis B,chronic /
- fatty liver /
- adefovir dipivoxil /
- treatment outcome
计量
- 文章访问数: 1671
- HTML全文浏览量: 10
- PDF下载量: 509
- 被引次数: 0